Itepekimab, Matched placebo for test product
EFC16750
Phase 3 small_molecule active
Quick answer
Itepekimab, Matched placebo for test product for Chronic Obstructive Pulmonary Disease is a Phase 3 program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pharma Bristol-Myers Squibb
- Indication
- Chronic Obstructive Pulmonary Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active